alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › drug-target

drug-target

5 studies tagged drug-target, dated 2008-10-01 to 2025-07-15. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging 2025-07-15
  2. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target 2022-02-12
  3. Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood 2021-08-11

Studies

5 studies carry this tag.

Date range

2008 to 2025

Top journals

  • Annals of the New York Academy of Sciences 1
  • Frontiers in pharmacology 1
  • Molecular neurobiology 1
  • Molecular psychiatry 1
  • Nature medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Nature medicine 2025-07-15 Caregiving

    More than 57 million people globally suffer from neurodegenerative diseases, a figure expected to double every 20 years.

  2. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Molecular neurobiology 2022-02-12 TREM2 and immune genetics

    Alzheimer's disease (AD) is an ever more common neurodegenerative disease among the elderly, characterized by recurrent neuroinflammation and amyloid beta (Aβ) accumulation in the brain parenchyma.

  3. Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular psychiatry 2021-08-11 Genetics

    Genome-wide association studies (GWASs) have discovered numerous risk genes for Alzheimer's disease (AD), but how these genes confer AD risk is challenging to decipher.

  4. Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in pharmacology 2019-08-23 TREM2 and immune genetics

    Alzheimer's disease (AD) is a large and increasing unmet medical need with no disease-modifying treatment currently available.

  5. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Annals of the New York Academy of Sciences 2008-10-01 Genetics

    Genome-wide association (GWA) can elucidate molecular genetic bases for human individual differences in complex phenotypes that include vulnerability to addiction.

All topic tags with their study counts